EQT Life Sciences

eqtgroup.com/private-capital/eqt-life-sciences

Formerly Life Sciences Partners (LSP) BV

Foreign Venture Capital Fund

Tech Verticals Preferences

Biotechnology, Diagnosis, ESG, Healthcare IT, Impact, Life Sciences, Medical Devices, MedTech

General Data

Current Active Portfolio Companies:

DESCRIPTION

EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced healthcare investors, targeting innovative life sciences and health care companies.

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
818A6689-B76B-EB11-B809-00505695CD29		EQT Private Equity
4D57EB44-207A-E111-AC59-00155D32A403	Investment Arm	EQT Life Sciences	EQT Private Equity

REMARKS

Date	Remark
01/03/2022	Following the signing of a definitive agreement to acquire LSP, EQT AB announced that the transaction was completed on February 28, 2022.

CONTACT INFO

Expand / Collapse All

Main Address: Amsterdam, The Netherlands

Address	9 Johannes Vermeerplein St.
City	Amsterdam
Country	The Netherlands
Zip	1071 DV

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Martijn Kleijwegt	Partner
Dr. Daniela Begolo	Managing Director

Investment Data

Managed Capital	abCDe
Capital Remarks	Capital raised (across 12 funds) ∼3.5b EUR

Preferences

Maximum investments	$68m
Minimum investments	$11m
Type of Financing	Equity
Stage Preferences	Initial Revenues,R&D,Seed

SECTOR SEGMENTATION (By Number Of Companies)

Biomed

100%

	PORTFOLIO COMPANIES

Current Portfolio Companies (1)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Eloxx

Biomed

Second Round - Extended

02/08/2017

N/A

$8m

Exits (1)

Company Name		Exit Type	Date Announced	Amount	Remarks
abC Defghij		Acquired	17/06/2007	abCDe	$28m in cash

Historic Portfolio (1)